ArticlePCN reports : psychiatry and clinical neurosciences2026
Adverse childhood experiences and neurodevelopmental disorder traits: A nationwide cross-sectional study.
Article in PCN reports : psychiatry and clinical neurosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: In this study, we aimed to examine the associations between adverse childhood experience (ACE) exposure, adult autism spectrum disorder (ASD), and attention-deficit/hyperactivity disorder (ADHD) traits in a nationwide sample, and assess links with specific symptom subdomains. Methods: We conducted a cross-sectional analysis using 2024 data from the Japan "Society and New Tobacco" Internet Survey. Adults ( Results: Among respondents, 4.9% reported experiencing ≥4 ACEs. Positive screening rates were 11.9% for ASD traits and 7.7% for ADHD traits. ASD traits were only associated with high ACE exposure (≥4 ACEs: odds ratio [OR] 1.29, 95% confidence intervals [CIs] 1.11-1.49). ADHD traits showed a dose-response relationship starting at 1 ACE (OR 1.15, 95% CI 1.00-1.31), and increased with greater exposure (≥4 ACEs: OR 1.70, 95% CI 1.45-1.98). High exposure was linked to specific ASD symptoms (e.g., social and communication difficulties) and ADHD symptoms (e.g., disorganization, task avoidance, and hyperactivity). Conclusion: ACEs were associated with adult ASD and ADHD traits and related symptom subdomains in adulthood.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.